MOLLY POUCHER: Open Payments
NPI 1154006948 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 27 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,439 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $284 |
| ABBVIE INC. | 7 | $160 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Alkermes, Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Lundbeck LLC | 2 | $53 |
| Exact Sciences Corporation | 2 | $31 |
| Amgen Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Wegovy, Ozempic, BREZTRI, VRAYLAR, REXULTI, LYBALVI, INGREZZA, UBRELVY.
Industry payments across FL — which companies pay providers there.
